Results 171 to 180 of about 72,493 (257)

Neoadjuvant Atezolizumab and Chemotherapy for Non‐Squamous Non‐Small Cell Lung Cancer: Efficacy and Safety Results of an Open‐Label, Single‐Arm, Phase II Trial

open access: yesInternational Journal of Cancer, Volume 159, Issue 6, Page 1510-1520, 15 September 2026.
Surgery plus chemotherapy is a well‐established treatment protocol for resectable, locally advanced non‐small cell lung cancer (NSCLC). Nonetheless, survival gains remain limited, emphasizing the need for more effective treatments. Here, the authors evaluated a novel approach using a neoadjuvant immunotherapy‐chemotherapy regimen consisting of ...
Benedikt Niedermaier   +19 more
wiley   +1 more source

Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial. [PDF]

open access: yesJ Peripher Nerv Syst
Brannagan TH   +12 more
europepmc   +1 more source

Rasch-Built Overall Disability Scale for Chronic Idiopathic Axonal Polyneuropathy. [PDF]

open access: yesNeurology
van der Star GM   +5 more
europepmc   +1 more source

Spectrum of Hereditary Neuropathies in Adult Patients From Serbia. [PDF]

open access: yesJ Peripher Nerv Syst
Vukojevic M   +10 more
europepmc   +1 more source

Inflammation, oxidative stress, matrix metalloproteinases and DNA damage in diabetic polyneuropathy and neuropathic pain. [PDF]

open access: yesFront Neurol
Ozdemir Gultekin T   +7 more
europepmc   +1 more source

Transitioning from efgartigimod to tacrolimus in chronic inflammatory demyelinating polyneuropathy: a prospective case series. [PDF]

open access: yesFront Immunol
Shen Y   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy